Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dolby Laboratories, Inc. (DLB) vs Nike Inc (NKE) Price & Performance

Dolby Laboratories, Inc.Trade

Price performance (Past 24H)

Key statistics

Dolby Laboratories, Inc. vs Nike Inc — how do they compare? Dolby Laboratories, Inc. trades at $58.95 (market cap $5.47B), while Nike Inc trades at $34.68 (market cap $51.60B). The key difference: Nike Inc is far larger — about 9.4× Dolby Laboratories, Inc.'s market cap, and Nike Inc pays the higher dividend (4.72%). Which is the better fit depends on your goals — on Pluang, investors hold Dolby Laboratories, Inc. for 98 Days and Nike Inc for 155 Days on average.

DLBNKE
Market Cap
$5.47B$51.60B
Volume
1,058,28443,506,062
Sector
TechnologyConsumer Cyclical
52-Week High
$70.09$69.68
52-Week Low
$48.51$33.87
Typical Hold Time
98 Days155 Days
Enterprise Value
$4.85B$54.30B
Dividend Yield
2.46%4.72%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dolby Laboratories, Inc.

DLB trades at $58.90, up 0.94% with bearish technical signals but strong fundamentals including 87.61% gross margins and consistent earnings beats. Recent expansion with Meta and leadership transition to Marc Whitten highlight growth initiatives. Cash flow improved significantly to $215.61M in 2025 from negative trends.

Analyst consensus targets $90.33 (53% upside) with 47% buy ratings, though technical indicators signal caution. Key risks include licensing volatility and execution during leadership change. Revenue stability and premium valuation at 24.87 P/E support long-term case if growth accelerates.

Nike Inc

Nike's stock trades at $34.36, down 0.72% with a bearish technical outlook. The company reported $46.31B in revenue for 2025 with a 6.74% net margin, though earnings have beaten expectations in recent quarters. Analyst consensus remains positive with a $36.98 price target, while recent news highlights challenges in China and inventory management.

Nike faces near-term headwinds from slowing revenue growth and margin pressure, but strong brand positioning and consistent earnings beats provide upside potential. Key risks include consumer demand weakness and competitive pressures, while institutional sentiment remains cautiously optimistic for a turnaround.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DLB

No sentiment data available yet.

NKE
59% Buy41% Sell
Avg holding period · 155 Days

Top news

Latest headlines on both assets

About Dolby Laboratories, Inc.

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.

Read more on DLB →

About Nike Inc

NIKE, Inc. designs, develops, and markets athletic footwear, apparel, equipment, and accessory products for men, women, and children. The Company sells its products worldwide to retail stores, through its own stores, subsidiaries, and distributors.

Read more on NKE →